Az Ige Orzoi: Tanulmanyok

Lab Reagents

Az Laboratories manufactures the az ige orzoi: tanulmanyok reagents distributed by Genprice. The Az Ige Orzoi: Tanulmanyok reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Az. Other Az products are available in stock. Specificity: Az Category: Ige Group: Orzoi: Tanulmanyok

Orzoi: Tanulmanyok information

AZ 628

A8371-25 25 mg
EUR 366
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase.

AZ 628

A8371-5 5 mg
EUR 157.2
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase.

AZ 628

A8371-5.1 10 mM (in 1mL DMSO)
EUR 166.8
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase.

AZ 628

A8371-50 50 mg
EUR 560.4
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase.

AZ 960

A4144-1 1 mg
EUR 217.2
Description: AZ960 is a novel inhibitor of janus-associated kinases (JAKs) that exhibits a potent inhibition against janus kinase 2 (JAK2) with the value of inhibition constant of Ki of 0.45 nmol/L. It also exhibits a lesser inhibitory effects against other JAKs family members

AZ 960

A4144-10 10 mg
EUR 932.4
Description: AZ960 is a novel inhibitor of janus-associated kinases (JAKs) that exhibits a potent inhibition against janus kinase 2 (JAK2) with the value of inhibition constant of Ki of 0.45 nmol/L. It also exhibits a lesser inhibitory effects against other JAKs family members

AZ 960

A4144-5 5 mg
EUR 616.8
Description: AZ960 is a novel inhibitor of janus-associated kinases (JAKs) that exhibits a potent inhibition against janus kinase 2 (JAK2) with the value of inhibition constant of Ki of 0.45 nmol/L. It also exhibits a lesser inhibitory effects against other JAKs family members

AZ 10417808

A4416-5 5 mg
EUR 459.6
Description: AZ 10417808 is a selective caspase-3 inhibitor with IC50 value of 14.9 uM [1].The caspase-3 protein is a member of the cysteine-aspartic acid protease (caspase) family.

AZ 11645373

B7362-10 10 mg
EUR 439.2
Description: AZ11645373 is identified as a highly selective and potent antagonist of human P2X7 receptors but not mouse/rat P2X7 receptors. Adenosine 5?-triphosphate (ATP)-gated P2X receptors (P2XRs) comprise of seven genes which encode plasma membrane ion channels for calcium cation.

AZ 11645373

B7362-50 50 mg
EUR 1654.8
Description: AZ11645373 is identified as a highly selective and potent antagonist of human P2X7 receptors but not mouse/rat P2X7 receptors. Adenosine 5?-triphosphate (ATP)-gated P2X receptors (P2XRs) comprise of seven genes which encode plasma membrane ion channels for calcium cation.

AZ-5104

HY-B0793 200mg
EUR 1250.4

AZ-1355

HY-101692 20mg
EUR 4027.2

AZ 628

HY-11004 10mM/1mL
EUR 187.2

AZ-23

HY-15590 100mg
EUR 2332.8

AZ 628

B1713-25 each
EUR 810

AZ 628

B1713-5 each
EUR 248.4

AZ-960

B2065-25 each
EUR 810